All In Biotech

Free tool

FAERS Monitor: Quiofic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216395 or its brand name (Quiofic, Folic Acid). Reports on generic versions are filed under their own applications.

Reports

250,981

Serious

186,221

74% of reports

Hospitalization

91,151

Death reported

23,615

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective25,501
  • fatigue24,215
  • pain23,889
  • arthralgia20,192
  • off label use18,427
  • rheumatoid arthritis18,093
  • nausea16,256
  • diarrhoea14,829
  • headache14,796
  • rash14,199
  • dyspnoea13,866
  • abdominal discomfort12,119
  • alopecia12,024
  • joint swelling11,899
  • condition aggravated11,648

Reports by year received

View as table
YearReports
20044,028
20053,947
20063,047
20073,025
20083,897
20095,191
20105,881
20117,320
201210,346
201311,131
201411,991
201514,840
201616,506
201714,724
201815,635
201916,226
202018,152
202116,635
202216,696
202314,171
202414,802
202513,764
20269,022

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,803,178 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal18,09315.715.5210,427
joint swellingSignal11,8999.18.977,291
abdominal discomfortSignal12,1196.46.352,164
alopeciaSignal12,0245.45.340,850
arthralgiaSignal20,1924.24.248,269
painSignal23,8893.43.338,996
condition aggravatedSignal11,6483.33.218,204
rashSignal14,1992.82.716,083
fatigueSignal24,2152.72.625,197
dyspnoeaSignal13,8662.12.07,784
headacheSignal14,7962.02.07,459
diarrhoea14,8291.91.96,883
off label use18,4271.81.86,432
nausea16,2561.71.75,166
drug ineffective25,5011.61.66,559

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.